Disclosures - H.M. Colhoun: Research Support; Current; Diabetes UK, IQVIA Inc., Sanofi, JDRF, Chief Scientist Office. Research Support; Ended; Medical Research Council (UKRI). Other - Personal payment for consultancy (ENDED); Research support (ongoing); Current; Sanofi. Other - Advisory board member (ongoing); Support for attendance at meetings /conferences and travel ; Current; Novo Nordisk. Other - Advisory panel member (ongoing); Stockholder (up to January 2025- ENDED); Current; Bayer AG. Other - Stockholder (ongoing); Institutional payment for consultancy (ongoing); Current; Roche Pharmaceuticals. J. Deanfield: Other - Received CME honoraria; Ended; Amgen Inc., Aegerion. Consultant; Current; AstraZeneca. Other - Member of Study Steering Committee for SOUL and SELECT; Current; Novo Nordisk. Other - Received CME honoraria; Ended; Bayer AG, Boehringer Ingelheim International GmbH. Other - Received CME honoraria; Current; Novo Nordisk. Research Support; Ended; British Heart Foundation, Alzheimer's Research UK, Pfizer, Colgate, Roche, Pfizer, Aegerion. Other - Advisory agreement.; Current; Caristo Diagnostics, eMed Healthcare, Floe Oral Care Ltd, Friede-Springer Cardiovascular Prevention Center, iOWNA, PMI Harm Reduction Group, Smarter Cardiovascular Outcomes By Research And Education L. S. Kahn: Advisory Panel; Current; AltPep, Amgen Inc., Congruence Therapeutics, Eli Lilly and Company, General Medicines, Kayothera, Merck & Co., Inc., Neurimmune, Novo Nordisk, Roche Pharmaceuticals. A.M. Lincoff: Consultant; Current; Novo Nordisk, Eli Lilly and Company. Stock/Shareholder; Current; Canary Cure. Research Support; Current; Novartis AG. Consultant; Ended; Alnylam Pharmaceuticals, Inc., Amgen Inc., Ardelyx, Brainstom Cell, Capricor, Johnson & Johnson. I. Lingvay: Consultant; Current; Aadvarak Therapeutics, Abbvie, Alveus Therapeutics, Amgen, Antag Therapeutics, Arrowhead Pharmaceuticals, Astra Zeneca, Baim Institute, Bain Capital, Bayer, Betagenon AB, Bioio Inc., Biomea, Boehringe. Research Support; Current; Novo Nordisk A/S, Dexcom, Inc., Boehringer Ingelheim International GmbH. Consultant; Current; Eli Lilly, Genentech, Janssen/J&J, Juvena, Keros Therapeutic, Inc, Mediflix, Metsera, Neurocrine, Novo Nordisk, Penguin Bio, Pfizer, Regeneron, Response Pharmaceutical, Roche, Sanofi, Shionogi, Skye B, Tenvie, TERNS Pharma, Verdiva Bio, Viking Therapeutics, and Zealand Pharma. J. Plutzky: Consultant; Current; Amgen Inc., Boehringer Ingelheim International GmbH, Corcept Therapeutics, Merck & Co., Inc., Novo Nordisk Foundation. K.B. Hessellund: Employee; Current; Novo Nordisk A/S. G.G. Hovingh: Employee; Current; Novo Nordisk A/S. K.J. Kolnes: Employee; Current; Novo Nordisk. Stock/Shareholder; Current; Novo Nordisk. P.E. Weeke: Employee; Current; Novo Nordisk. L. Bjerre Knudsen: Employee; Current; Novo Nordisk. J. Refsgaard: Employee; Current; Novo Nordisk A/S.

Rajesh Garg

UCLA David Geffen School of Medicine

Appearances